ØRE- NÆSE- HALSKLINIKKEN I GREVE ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark

 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Bankruptcy risk for industry  0.7% 0.7% 0.7% 0.7% 0.7%  
Bankruptcy risk  1.3% 1.5% 1.4% 1.5% 1.6%  
Credit score (0-100)  80 76 78 75 75  
Credit rating  A A A A A  
Credit limit (kDKK)  44.2 10.2 29.0 11.2 7.4  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Net sales  0 0 0 0 0  
Gross profit  3,205 3,364 3,366 3,407 3,567  
EBITDA  1,512 1,562 1,455 1,490 1,556  
EBIT  1,462 1,503 1,382 1,461 1,527  
Pre-tax profit (PTP)  1,466.2 1,504.6 1,370.3 1,412.3 1,516.6  
Net earnings  1,143.2 1,173.4 1,069.0 1,103.1 1,180.4  
Pre-tax profit without non-rec. items  1,466 1,505 1,370 1,412 1,517  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Tangible assets total  150 218 145 116 86.9  
Shareholders equity total  1,287 611 1,230 1,228 1,309  
Interest-bearing liabilities  0.0 112 53.4 0.0 0.0  
Balance sheet total (assets)  1,996 1,362 1,849 1,873 1,834  

Net Debt  -685 -414 -802 -29.5 -138  
 
See the entire balance sheet

Volume 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  3,205 3,364 3,366 3,407 3,567  
Gross profit growth  25.7% 5.0% 0.0% 1.2% 4.7%  
Employees  3 4 0 0 0  
Employee growth %  0.0% 33.3% -100.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,996 1,362 1,849 1,873 1,834  
Balance sheet change%  53.6% -31.7% 35.7% 1.3% -2.1%  
Added value  1,511.6 1,561.7 1,454.9 1,533.8 1,556.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -77 9 -145 -58 -58  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  5.0 5.0 5.0 5.0 5.0  

Profitability 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  45.6% 44.7% 41.1% 42.9% 42.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  89.1% 89.8% 86.1% 78.5% 82.4%  
ROI %  152.3% 150.1% 137.8% 116.4% 120.4%  
ROE %  140.2% 123.6% 116.2% 89.8% 93.1%  

Solidity 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Equity ratio %  64.5% 44.8% 66.5% 65.6% 71.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -45.3% -26.5% -55.1% -2.0% -8.9%  
Gearing %  0.0% 18.3% 4.3% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  1.5% 6.3% 14.4% 182.5% 0.0%  

Liquidity 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Quick Ratio  2.6 1.5 2.8 2.7 3.3  
Current Ratio  2.6 1.5 2.8 2.7 3.3  
Cash and cash equivalent  685.1 525.1 855.6 29.5 138.0  

Capital use efficiency 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1,137.8 393.1 1,084.9 1,112.2 1,221.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Net sales / employee  0 0 0 0 0  
Added value / employee  504 390 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  504 390 0 0 0  
EBIT / employee  487 376 0 0 0  
Net earnings / employee  381 293 0 0 0